Drug
Syh9061
Syh9061: highest development phase Phase 2, developed by CSPC-NBP Pharmaceutical Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSPC-NBP Pharmaceutical Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| SYH9061 NCT07933133 | Phase 2 | Idiopathic Pulmonary Fibrosis |
Latest
No recent events.
Follow Syh9061 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.